Yun, D., Yang, Z., Zhang, S., Yang, H., Liu, D., Grützmann, R., . . . Britzen-Laurent, N. (2022). An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer. Friedrich-Alexander-Universität Erlangen-Nürnberg.
Chicago-Zitierstil (17. Ausg.)Yun, Duo, Zhirong Yang, Shuman Zhang, Hai Yang, Dongxue Liu, Robert Grützmann, Christian Pilarsky, und Nathalie Britzen-Laurent. An M5C Methylation Regulator-associated Signature Predicts Prognosis and Therapy Response in Pancreatic Cancer. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.
MLA-Zitierstil (9. Ausg.)Yun, Duo, et al. An M5C Methylation Regulator-associated Signature Predicts Prognosis and Therapy Response in Pancreatic Cancer. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.